[PETN: long acting nitrate with tolerance devoiding properties and innovative potential].
Richartz
B M
BM
Kardiologische Praxis und Herzdiagnostikzentrum, München.
Schneider
H T
HT
Silber
S
S
D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D000818:Animals; D016001:Confidence Intervals; D004195:Disease Models, Animal; D004361:Drug Tolerance; D004730:Endothelium, Vascular / Q000503:physiopathology; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007548:Isosorbide Dinitrate / Q000494:pharmacology; D051379:Mice; D015337:Multicenter Studies as Topic; D018384:Oxidative Stress; D010417:Pentaerythritol Tetranitrate / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012907:Smoking / Q000009:adverse effects; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D014665:Vasodilator Agents; D010417:Pentaerythritol Tetranitrate; D007548:Isosorbide Dinitrate